Merck KGaA, Darmstadt, Germany, receives Halal certifications for cosmetics effect and care solutions portfolio
- 284 products comply with several international recognized halal standards
- Origin of each individual ingredient and the supply chain of the products that are purchased and used adhere to religious prescriptions
- Growing demand for halal-certified ingredients in Islamic countries
Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that the entire cosmetics portfolio as well as the Candurin® portfolio for food and pharmaceuticals have been certified according to several international recognized halal standards. Thus, their portfolio of halal certified products now also includes special effect pigments, cosmetic ingredients, functional fillers, and food colorants. The almost 300 products complement around 800 halal certified products, that are already offered by the Life Science business sector of Merck KGaA, Darmstadt, Germany.
“There is an increasing demand for halal products across the globe, more prominently in Muslim dominated countries. Our portfolio now offers a wide range of halal certified cosmetics products and solutions.” Dorothea Wenzel, Head of Surface Solutions at the Electronics business sector of Merck KGaA, Darmstadt, Germany, explained. “Today, many customers have a particular high awareness regarding the ingredients of the cosmetics products they use, and we see that the importance of this aspect continuously increases.” The global market of halal-compliant cosmetic is expected to significantly grow in the upcoming years.
Halal products are sourced and manufactured with ingredients that are “permissible” under Islamic law. Along the entire value chain, strict guidelines for raw material purchasing, manufacturing, filling, warehousing, and transport are followed to ensure product purity in compliance with religious prescriptions.
Therefore, the production facilities of their manufacturing sites in Darmstadt, Gernsheim, Mollet, Onahama and Savannah had to ensure that they are producing in accordance with the individual halal standards.
For the certification, Merck KGaA, Darmstadt, Germany, worked with a network of certification bodies across the globe. Halal Quality Control, Darmstadt (HQC) audited and certified the German sites Darmstadt and Gernsheim as well as Mollet in Spain. The U.S.-based site in Savannah, Georgia, has been certified by the Islamic Food and Nutrition Council of America (IFANCA), whereas the site in Onahama, Japan was inspected and certified by the Japan Halal Association (JHA).
All Merck KGaA, Darmstadt, Germany, press releases are distributed by e-mail at the same time they become available on the EMD Group Website. In case you are a resident of the USA or Canada please go to www.emdgroup.com/subscribe to register for your online subscription of this service as our geo-targeting requires new links in the email. You may later change your selection or discontinue this service.
About Merck KGaA, Darmstadt, Germany
Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics. Around 58,000 employees work to make a positive difference to millions of people’s lives every day by creating more joyful and sustainable ways to live. From advancing gene editing technologies and discovering unique ways to treat the most challenging diseases to enabling the intelligence of devices – the company is everywhere. In 2020, Merck KGaA, Darmstadt, Germany, generated sales of € 17.5 billion in 66 countries.
The company holds the global rights to the name and trademark “Merck” internationally. The only exceptions are the United States and Canada, where the business sectors of Merck KGaA, Darmstadt, Germany operate as EMD Serono in healthcare, MilliporeSigma in life science, and EMD Electronics. Since
its founding in 1668, scientific exploration and responsible entrepreneurship have been key to the company’s technological and scientific advances. To this day, the founding family remains the majority owner of the publicly listed company.
Merck KGaA today shared updates on the company’s healthcare research and development strategy, aimed at doubling R&D productivity.